Yazar "Boga, Mehmet" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • Küçük Resim Yok
    Öğe
    Comparative Analysis of Antioxidant, Anticholinesterase, and Antibacterial Activity of Microbial Chondroitin Sulfate and Commercial Chondroitin Sulfate
    (Wiley-V C H Verlag Gmbh, 2023) Unver, Tuba; Erenler, Ayse Sebnem; Bingul, Murat; Boga, Mehmet
    Chondroitin synthesis was performed using the recombinant Escherichia coli(C2987) strain created by transforming the plasmid pETM6-PACF-vgb, which carries the genes responsible for chondroitin synthesis, kfoA, kfoC, kfoF, and the Vitreoscilla hemoglobin gene (vgb). Then, Microbial chondroitin sulfate (MCS)'s antioxidant, anticholinesterase, and antibacterial activity were compared with commercial chondroitin sulfate (CCS). The antioxidant studies revealed that the MCS and CCS samples could be potential targets for scavenging radicals and cupric ion reduction. MCS demonstrated better antioxidant properties in the ABTS assay with the IC50 value of 0.66 mg than CCS. MCS showed 2.5-fold for DPPH and almost 5-fold for ABTS *+ (with a value of 3.85 mg/mL) better activity than the CCS. However, the compounds were not active for cholinesterase enzyme inhibitions. In the antibacterial assay, the Minimum inhibitory concentration (MIC) values of MCS against S. aureus, E. aerogenes, E. coli, P. aeruginosa, and K. pneumoniae (0.12, 0.18, 0.12, 0.18, and 0.18 g/mL, respectively) were found to be greater than that of CCS (0.42, 0.48, 0.36, 0.36, and 0.36 g/mL, respectively). This study demonstrates that MCS is a potent pharmacological agent due to its physicochemical properties, and its usability as a therapeutic-preventive agent will shed light on future studies.
  • Küçük Resim Yok
    Öğe
    Shedding Light on the Phytochemical and Biological Fingerprints of Fibigia clypeata (L.) Medik Essential Oil as a Pharmacotherapeutic Agent
    (Wiley, 2025) Unver, Tuba; Bingul, Murat; Uslu, Harun; Gurhan, Ismet; Goktas, Bunyamin; Sahin, Hasan; Boga, Mehmet
    Since plant essential oil contains medicinally valuable compounds, its usability as a pharmacotherapeutic agent has been the focus of attention within the century's needs. The lack of sufficient studies on the medical and pharmacological evaluation of Fibigia clypeata (L.) Medik has made this plant the target of our study. This study analyzes the phytochemical composition and biological activity of F. clypeata essential oil. As a result, dimethyl disulfide and dimethyl trisulfide were found to be the main compounds of the plant essential oil, with rates of 73.13% and 19.87%, respectively. The antifungal property of plant essential oil is more effective than its antibacterial property, with MIC values ranging between 0.039 and 0.312 mu L/mL for fungal species and up to 3.750 mu L/mL for bacterial species. The enzyme inhibition profiles were investigated towards two enzymes, namely, anticholinesterase and alpha-glucosidase, targeted for anti-diabetic studies. Anticholinesterase activity was proved with the IC50 values of 17.31 and 4.78 mu g/mL for Acetylcholinesterase (AChE) and Butyrylcholinesterase (BChE) enzymes, respectively. DPPH and CUPRAC activities were the most promising antioxidant studies, with values of 1.54 and 3.72 mu g/mL. It was observed that alpha-Terpineol made a hydrogen bond with ASN80, and 1-(2,6,6-Trimethyl-1,3-cyclohexadien-1-yl)ethanol made a hydrogen bond with SER82. Although molecular dock scores were better for antifungal activity, it was determined that no interactions, such as hydrogen bonding or pi interaction, were observed. This preliminary study showed that F. clypeata essential oil is a natural source with promising in vitro antimicrobial, antioxidant, and anticholinesterase activities that warrants further investigation, including safety assessments, due to the high concentration of sulfur-containing compounds. Molecular docking and ADME prediction results showed that alpha-Terpineol and 1-(2,6,6-Trimethyl-1,3-cyclohexadien-1-yl)ethanol were more prone to antimicrobial activity.
  • Küçük Resim Yok
    Öğe
    Synthesis, Characterization, Anticholinesterase, and Antioxidant Properties of Quinoxalin-2(1H)-One Functionalized (Benz)Imidazol-3-Ium Salts as Hybrid Molecules in Drug Discovery
    (Wiley-V C H Verlag Gmbh, 2026) Kaloglu, Nazan; Boga, Mehmet; Ercan, Selami; Cinar, Ercan; Bektasli, Yonca; Kaloglu, Murat
    In the present study, biologically active quinoxalin-2(1H)-one and (benz)imidazole scaffolds were successfully integrated into single hybrid molecules. As a result, five new quinoxalin-2(1H)-one-functionalized (benz)imidazol-3-ium salts were synthesized. The structures of these newly designed hybrids, synthesized for the first time, were confirmed through spectroscopic techniques and elemental analysis. The in vitro anticholinesterase activities of the hybrids were evaluated against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). In addition, their antioxidant potentials were investigated using DPPH (1,1-diphenyl-2-picrylhydrazyl) and ABTS (2,2 '-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) radical scavenging assays, along with the CUPRAC (cupric ion reducing antioxidant capacity) method. Furthermore, molecular docking studies of the molecules were performed to investigate ligand-residue interactions in addition to their probable binding modes in the binding site of AChE and BChE enzymes. The results obtained indicate that the synthesized hybrid molecules possess promising anticholinesterase and antioxidant properties and hold potential as therapeutic candidates for the treatment of Alzheimer's disease.